Riken Vitamin Co., Ltd.
FY2026 Q3 Financial Summary (Japanese GAAP) (Consolidated)
For the third quarter of FY2026, consolidated net sales were 72,503 million yen (down 0.5% YoY), operating income was 5,716 million yen (down 24.2% YoY), and net income attributable to owners of the parent was 5,949 million yen (up 2.0% YoY).
Key Figures
- Net Sales: 72,503 million yen (Down 0.5% YoY)
- Operating Income: 5,716 million yen (Down 24.2% YoY)
- Net Income Attributable to Owners of Parent: 5,949 million yen (Up 2.0% YoY)
AI要約
Overview of Business Results
For the cumulative consolidated period of Q3 FY2026, net sales were 72,503 million yen, a 0.5% decrease year-over-year. Operating income was 5,716 million yen, down 24.2%, and ordinary income was 6,403 million yen, down 22.3%. However, net income attributable to owners of the parent increased 2.0% to 5,949 million yen. In the domestic food business, household food sales declined, whereas commercial food and processed food raw materials increased. Overseas business sales decreased, recording an operating loss. Profit was reduced due to a revision in asset retirement obligations related to asbestos removal costs.
Financial Position and Dividend Status
Total assets increased from the end of the previous consolidated fiscal year to 116,694 million yen, and net assets also increased to 81,974 million yen. The number of treasury stock shares increased compared to the same period last year. The annual dividend is forecasted at 110 yen with no revisions from the previous forecast. Note that earnings guidance has been partially revised; please refer to the separately announced “Notice Regarding Revision of Earnings Forecast” for details.
